News › Funding

Lillia scores a $1.7 million grant from Qatar Research Council

February 24, 2025
Lillia logo

The AI startup transforming chronic care for a healthier world Lillia — formely known as DroobiSmit and before that as Droobi Health — has received a $1.7 million grant from Qatar Research, Development and Innovation (QRDI) Council to develop the first digital twin in the GCC area that focuses on chronic conditions.

The company envisions a chronic care digital twin paired with AI agents to bring predictive capabilities to the platform and unlock applications in real-time risk monitoring and precision medication, among other use cases.

Backed by investors such as Qatar Development Bank, QSTP and M Venture Partners - Lillia is scaling rapidly to become a global leader in AI-led chronic disease management. Over the next two years, the company plans to expand its services across MENA and Southeast Asia regions.

Funding 💰

Round $1.7M
Grant
Lead investor(s) Qatar Research, Development and Innovation (QRDI) Council

Quotes 💬

“
Diabetes and related chronic conditions are the world's biggest healthcare challenge, affecting more than 500 million people. The good news is with the right interventions, diabetes can be prevented and reversed in the early stages or effectively managed for long-term health. "Lillia exists to lower the chronic disease burden for the world by providing continuous adaptive care that drives a real and lasting lifestyle change.
— Sujit Chakrabarty, Lillia's founder and CEO
“
At QRDI Council, we're proud to support Lillia as they push the boundaries of healthcare innovation with their AI-driven digital twin technology. Through our Technology Development Grant program, we empower pioneering companies like Lillia to bring transformative technology solutions to life, advancing healthcare, enhancing quality of life, and positioning Qatar as a leader in digital transformation. This partnership reinforces our shared commitment to creating a lasting impact for communities both locally and globally.
— Nada Al-Olaqi, Director of Innovation Development and Piloting Programs at QRDI Council

About 🏢

Formerly known as Droobi Health and then DroobiSmit, Lillia has built a bilingual digital health solution available in English and Arabic to help people prevent or manage chronic conditions that rely on lifestyle support, such as diabetes and obesity. The company's AI-enabled digital therapeutics product combines a mobile app, remote monitoring tools, online access to a real human health coach, and a behavior change platform to enable people to live healthier lives. In January 2024, Droobi Health merged with Smit.fit to form DroobiSmit - which was later renamed to Lillia. In addition to Qatar, the company has an office in Singapore. more
source

Latest @ DH Arab

MoHAP, Sanofi sign MoU to help prevent Chronic Respiratory Diseases and combat tobacco use

M42 announces results for its AI-powered tuberculosis screening

UAE's MoHAP clears the bureaucratic cobwebs with bold new overhaul

Oman's AI breakthrough in genetic heart disorder detection

Saudi Arabia launches new Medical Referral Center with 15 key responsibilities

💡Did you know?

You can take your DHArab experience to the next level with our Premium Membership.
👉 Click here to learn more

🛠️Featured tool

Easy-Peasy Easy-Peasy
An all-in-one AI tool offering the ability to build no-code AI Bots, create articles & social media posts, convert text into natural speech in 40+ languages, create and edit images, generate videos, and more.
👉 Click here to learn more